|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.05 CHF | +0.54% |
|
+0.30% | +13.05% |
| 04-14 | Spanish stocks - Factors to watch on April 14 | RE |
| 04-10 | Galenica AG Approves Election of Nadine Balkanyi-Nordmann as New Member of the Board of Directors | CI |
| Capitalization | 4.19B 5.05B 4.44B 3.79B 7B 431B 7.91B 48.95B 19B 194B 18.94B 18.55B 727B | P/E ratio 2025 * |
23.5x | P/E ratio 2026 * | 22.2x |
|---|---|---|---|---|---|
| Enterprise value | 4.75B 5.73B 5.04B 4.31B 7.94B 489B 8.98B 55.58B 21.58B 220B 21.51B 21.06B 825B | EV / Sales 2025 * |
1.16x | EV / Sales 2026 * | 1.11x |
| Free-Float |
99.44% | Yield 2025 * |
2.8% | Yield 2026 * | 2.92% |
More valuation ratios
* Estimated data
More news
Last Transcript: Galenica AG
More recommendations
More press releases
More news
| 1 day | +0.54% | ||
| 1 week | +0.30% | ||
| Current month | +5.72% | ||
| 1 month | +5.66% | ||
| 3 months | +5.92% | ||
| 6 months | +9.30% | ||
| Current year | +13.05% |
| 1 week | 81.9 |  | 84.55 |
| 1 month | 76.75 | | 84.55 |
| Current year | 74.1 | | 86.7 |
| 1 year | 69.75 | | 86.7 |
| 3 years | 64.5 | | 86.7 |
| 5 years | 57.15 | | 86.7 |
| 10 years | 41.8 | | 86.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 58 | 2020-03-31 |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 53 | 2021-12-31 |
Marianne Hasler
HRO | Human Resources Officer | 46 | 2023-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertrand Jungo
BRD | Director/Board Member | 60 | 2017-12-31 |
| Chairman | 67 | 2023-05-02 | |
Pascale Bruderer
BRD | Director/Board Member | 48 | 2019-12-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.17% | 1,022 M€ | +11.75% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.54% | +0.30% | +19.47% | +16.57% | 5.05B | ||
| +0.95% | -0.30% | +28.72% | +119.03% | 87.1B | ||
| +1.27% | +2.12% | +32.51% | +124.62% | 33.23B | ||
| -1.95% | +1.01% | - | - | 22.19B | ||
| -4.08% | -2.49% | +14.87% | +25.74% | 9.03B | ||
| -0.33% | -1.67% | +2.41% | +6.85% | 8.26B | ||
| -0.46% | -1.91% | -19.91% | +3.20% | 7.01B | ||
| +0.05% | -0.90% | +2.99% | -15.58% | 4.39B | ||
| +0.07% | +3.57% | -9.15% | - | 4.35B | ||
| -1.04% | +0.63% | -1.02% | +16.97% | 3.45B | ||
| Average | -0.50% | -0.22% | +7.88% | +37.18% | 18.41B | |
| Weighted average by Cap. | +0.21% | -0.53% | +22.64% | +94.56% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.1B 4.94B 4.35B 3.71B 6.85B 422B 7.74B 47.91B 18.6B 190B 18.54B 18.15B 711B | 4.24B 5.12B 4.5B 3.84B 7.09B 437B 8.01B 49.61B 19.26B 197B 19.2B 18.8B 737B |
| Net income | 177M 214M 188M 161M 297M 18.27B 335M 2.07B 805M 8.22B 803M 786M 30.81B | 188M 227M 200M 171M 315M 19.38B 355M 2.2B 854M 8.72B 851M 834M 32.68B |
| Net Debt | 567M 684M 602M 514M 947M 58.36B 1.07B 6.63B 2.57B 26.27B 2.56B 2.51B 98.42B | 528M 637M 561M 479M 883M 54.38B 997M 6.18B 2.4B 24.48B 2.39B 2.34B 91.71B |
More financial data
* Estimated data
Employees
6,241
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-04-25 | 84.05 CHF | +0.54% | 87,613 |
| 25-04-24 | 83.60 CHF | +1.33% | 86,158 |
| 25-04-23 | 82.50 CHF | -0.78% | 104,607 |
| 25-04-22 | 83.15 CHF | -0.78% | 67,649 |
| 25-04-17 | 83.80 CHF | +0.66% | 102,868 |
Delayed Quote Swiss Exchange, April 25, 2025 at 11:31 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
84.05CHF
Average target price
80.25CHF
Spread / Average Target
-4.52%
Annual profits - Rate of surprise
- Stock Market
- Equities
- GALE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition